Moderna Inc
(XSWX:MRNA)
CHF
57.81
(0%)
Market Cap: 25.61 Bil
Enterprise Value: 22.45 Bil
PE Ratio: 0
PB Ratio: 3.88
GF Score: 62/100 Moderna Inc at Bank of America Global Healthcare Conference Transcript
May 12, 2026 / 06:20PM GMT
Release Date Price:
CHF42.24
(-2.09%)
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
All right. I guess it's quiet, so we'll probably get going then. Thanks for joining the session with Moderna Therapeutics, and thanks for attending the 2026 Bank of America Healthcare Conference. My name is Alex Stranahan. I'm a senior biotech analyst at Bank of America covering Moderna.
And I'm pleased to be joined by Lavina Talukdar, Head of Investor Relations. Lavina, thanks for being here.
Lavina Talukdar Moderna Inc;Senior Vice President
Head Investor Relations
Thank you so much for having me. That was the best pronunciation of my last name.
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
Been practicing. But just for this.
Questions & Answers
Alec Stranahan
Bofa Merrill Lynch Asset Holdings Inc - Analyst
But maybe just to start, you've got four approved products. You've guided to revenue growth for 2026. You've already beaten your own reduction
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot